Skip to main content

Table 5 DAI-10 score by treatment group and by presence/absence of EPS.

From: Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)

Patients with

 

OLZ

RIS

HAL

p-value

EPS

 

N = 688

N = 189

N = 79

 

Baseline

Mean

0,45

-0,36

-1,31

OLZ vs RIS, NS; OLZ vs HAL,

     

p < 0,05; RIS vs HAL, NS

 

SD

5,12

5,27

5,16

 
 

Median

0

0

0

 
 

n of observations

667

184

72

 

6 months

Mean

4,13

2,95

0,87

OLZ vs RIS, P = 0,0031; OLZ vs HAL,

     

p < 0,001; RIS vs HAL, P = 0,0015

 

SD

437

4,75

4,8

 
 

Median

6

4

2

 
 

n of observations

594

170

69

 

Patients

 

OLZ

RIS

HAL

p-value

without EPS

 

N = 1175

N = 192

N = 25

 

Baseline

Mean

-0,02

0,82

-0,17

OLZ vs RIS, NS; OLZ vs HAL, NS; RIS vs HAL, NS

 

SD

5,51

5,19

5,72

 
 

Median

0

2

0

 
 

n of observations

1118

178

24

 

6 months

Mean

4,9

3,85

4,42

OLZ vs RIS, p = 0,033; OLZ vs HAL, NS; RIS vs HAL, NS

 

SD

43

5,15

534

 
 

Median

6

6

6

 
 

n of observations

1128

183

24